Beth Israel Deaconess Medical Center Angiographic Core Lab FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Sep 24, 2015
  • No warning letters matched by name
Inspections 3 0 OAI
Recalls 0 0 Class I
Warning letters 0 None on file
510(k) clearances 0 None on file

Beth Israel Deaconess Medical Center Angiographic Core Lab has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Beth Israel Deaconess Medical Center Angiographic Core Lab" is on file.

What these totals cover: FDA records filed under the name "Beth Israel Deaconess Medical Center Angiographic Core Lab".

Latest inspection
Sep 24, 2015 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections3Nov 15, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Beth Israel Deaconess Medical Center Angiographic Core Lab as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Beth Israel Deaconess Medical Center Angiographic Core Lab yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

3 inspections from Apr 14, 2011 to Sep 24, 2015.

DateSiteProductClassificationFEI
Sep 24, 2015Boston, MADevicesNo Action Indicated (NAI)3008767943
Aug 4, 2011Boston, MADevicesNo Action Indicated (NAI)3008767943
Apr 14, 2011Boston, MADevicesNo Action Indicated (NAI)3008767943
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3008767943Boston, MA3Sep 24, 2015

Beth Israel Deaconess Medical Center Angiographic Core Lab and the FDA: common questions

Has Beth Israel Deaconess Medical Center Angiographic Core Lab received an FDA warning letter?

No FDA warning letter addressed to the name "Beth Israel Deaconess Medical Center Angiographic Core Lab" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Beth Israel Deaconess Medical Center Angiographic Core Lab received an FDA Form 483?

FDA has not published a Form 483 for "Beth Israel Deaconess Medical Center Angiographic Core Lab" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Beth Israel Deaconess Medical Center Angiographic Core Lab?

The most recent FDA inspection on file ended Sep 24, 2015 at Boston, MA and was classified NAI. FDA has 3 inspections of Beth Israel Deaconess Medical Center Angiographic Core Lab on file.

Need more than this page shows? Ask about Beth Israel Deaconess Medical Center Angiographic Core Lab in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.